VENTRIPOINT DIAGNOSTICS LTD. Financials Ventripoint Diagnostics Ltd.
Equities
VPT
CA92281P2008
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.245 CAD | 0.00% |
|
-2.00% | -16.95% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9.319 | 5.212 | 8.035 | 53.67 | 42.34 | 46.26 |
| Enterprise Value (EV) 1 | 9.253 | 6.323 | 8.879 | 44.56 | 37.62 | 45.38 |
| P/E ratio | -4.13 x | -1.43 x | -3.62 x | -12.1 x | -8.64 x | -9.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 155 x | 64.3 x | 223 x | - | 621 x | 941 x |
| EV / Revenue | 154 x | 78 x | 247 x | - | 552 x | 923 x |
| EV / EBITDA | -2.44 x | -1.94 x | -4.7 x | -12 x | -7.67 x | -9.21 x |
| EV / FCF | -2.51 x | -4.23 x | -11.8 x | -20.6 x | -14.6 x | -21.6 x |
| FCF Yield | -39.9% | -23.7% | -8.45% | -4.85% | -6.83% | -4.64% |
| Price to Book | -9.58 x | -2.11 x | -3.45 x | 6.44 x | 9.3 x | 244 x |
| Nbr of stocks (in thousands) | 60,125 | 69,487 | 89,274 | 1,55,559 | 1,56,824 | 1,56,824 |
| Reference price 2 | 0.1550 | 0.0750 | 0.0900 | 0.3450 | 0.2700 | 0.2950 |
| Announcement Date | 29/04/19 | 29/04/20 | 03/05/21 | 03/05/22 | 01/05/23 | 30/04/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0602 | 0.081 | 0.036 | - | 0.0682 | 0.0492 |
| EBITDA 1 | -3.795 | -3.258 | -1.89 | -3.702 | -4.902 | -4.925 |
| EBIT 1 | -3.823 | -3.283 | -1.91 | -3.715 | -4.911 | -4.93 |
| Operating Margin | -6,353.31% | -4,051.66% | -5,302.63% | - | -7,203.96% | -10,024.8% |
| Earnings before Tax (EBT) 1 | -2.084 | -3.323 | -1.851 | -3.881 | -4.873 | -4.872 |
| Net income 1 | -2.084 | -3.323 | -1.851 | -3.881 | -4.873 | -4.872 |
| Net margin | -3,463.14% | -4,100.85% | -5,138.34% | - | -7,148.33% | -9,905.73% |
| EPS 2 | -0.0375 | -0.0524 | -0.0248 | -0.0285 | -0.0312 | -0.0311 |
| Free Cash Flow 1 | -3.688 | -1.496 | -0.7499 | -2.162 | -2.569 | -2.106 |
| FCF margin | -6,129.39% | -1,846.96% | -2,081.98% | - | -3,768.52% | -4,281.46% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/04/19 | 29/04/20 | 03/05/21 | 03/05/22 | 01/05/23 | 30/04/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 1.11 | 0.84 | - | - | - |
| Net Cash position 1 | 0.07 | - | - | 9.11 | 4.73 | 0.88 |
| Leverage (Debt/EBITDA) | - | -0.3412 x | -0.4464 x | - | - | - |
| Free Cash Flow 1 | -3.69 | -1.5 | -0.75 | -2.16 | -2.57 | -2.11 |
| ROE (net income / shareholders' equity) | 160% | 193% | 76.8% | -130% | -75.6% | -205% |
| ROA (Net income/ Total Assets) | -220% | -526% | -214% | -44.9% | -39.5% | -78.4% |
| Assets 1 | 0.9491 | 0.6322 | 0.865 | 8.646 | 12.32 | 6.213 |
| Book Value Per Share 2 | -0.0200 | -0.0400 | -0.0300 | 0.0500 | 0.0300 | 0 |
| Cash Flow per Share 2 | 0 | 0 | 0.0100 | 0.0600 | 0.0300 | 0.0100 |
| Capex 1 | 0.03 | 0.02 | 0 | 0 | - | - |
| Capex / Sales | 45.49% | 21.1% | 10.45% | - | - | - |
| Announcement Date | 29/04/19 | 29/04/20 | 03/05/21 | 03/05/22 | 01/05/23 | 30/04/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -16.95% | 28.19M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- VPT Stock
- Financials Ventripoint Diagnostics Ltd.
